185 related articles for article (PubMed ID: 20395273)
21. Immunoglobulin-regulated expression of Borrelia burgdorferi outer surface protein A in vivo.
Hodzic E; Tunev S; Feng S; Freet KJ; Barthold SW
Infect Immun; 2005 Jun; 73(6):3313-21. PubMed ID: 15908357
[TBL] [Abstract][Full Text] [Related]
22. Flagellin and outer surface proteins from Borrelia burgdorferi are not glycosylated.
Sterba J; Vancová M; Rudenko N; Golovchenko M; Tremblay TL; Kelly JF; MacKenzie CR; Logan SM; Grubhoffer L
J Bacteriol; 2008 Apr; 190(7):2619-23. PubMed ID: 18245287
[TBL] [Abstract][Full Text] [Related]
23. Borrelia burgdorferi oxidative stress regulator BosR directly represses lipoproteins primarily expressed in the tick during mammalian infection.
Wang P; Dadhwal P; Cheng Z; Zianni MR; Rikihisa Y; Liang FT; Li X
Mol Microbiol; 2013 Sep; 89(6):1140-53. PubMed ID: 23869590
[TBL] [Abstract][Full Text] [Related]
24. The extended promoters for two outer membrane lipoprotein genes of Borrelia spp. uniquely include a T-rich region.
Sohaskey CD; Zückert WR; Barbour AG
Mol Microbiol; 1999 Jul; 33(1):41-51. PubMed ID: 10411722
[TBL] [Abstract][Full Text] [Related]
25. Structural and molecular analysis of a protective epitope of Lyme disease antigen OspA and antibody interactions.
Shandilya S; Kurt Yilmaz N; Sadowski A; Monir E; Schiller ZA; Thomas WD; Klempner MS; Schiffer CA; Wang Y
J Mol Recognit; 2017 May; 30(5):. PubMed ID: 27859766
[TBL] [Abstract][Full Text] [Related]
26. Translocation of Borrelia burgdorferi surface lipoprotein OspA through the outer membrane requires an unfolded conformation and can initiate at the C-terminus.
Schulze RJ; Chen S; Kumru OS; Zückert WR
Mol Microbiol; 2010 Jun; 76(5):1266-78. PubMed ID: 20398211
[TBL] [Abstract][Full Text] [Related]
27. Host-adapted Borrelia burgdorferi in mice expresses OspA during inflammation.
Crowley H; Huber BT
Infect Immun; 2003 Jul; 71(7):4003-10. PubMed ID: 12819088
[TBL] [Abstract][Full Text] [Related]
28. Temporal regulation of outer surface proteins of the Lyme-disease spirochaete Borrelia burgdorferi.
Schwan TG
Biochem Soc Trans; 2003 Feb; 31(Pt 1):108-12. PubMed ID: 12546665
[TBL] [Abstract][Full Text] [Related]
29. Temporal pattern of Borrelia burgdorferi p21 expression in ticks and the mammalian host.
Das S; Barthold SW; Giles SS; Montgomery RR; Telford SR; Fikrig E
J Clin Invest; 1997 Mar; 99(5):987-95. PubMed ID: 9062357
[TBL] [Abstract][Full Text] [Related]
30. Immunization with a recombinant subunit OspA vaccine markedly impacts the rate of newly acquired Borrelia burgdorferi infections in client-owned dogs living in a coastal community in Maine, USA.
Eschner AK; Mugnai K
Parasit Vectors; 2015 Feb; 8():92. PubMed ID: 25890386
[TBL] [Abstract][Full Text] [Related]
31. Essential role for OspA/B in the life cycle of the Lyme disease spirochete.
Yang XF; Pal U; Alani SM; Fikrig E; Norgard MV
J Exp Med; 2004 Mar; 199(5):641-8. PubMed ID: 14981112
[TBL] [Abstract][Full Text] [Related]
32. Genetic diversity of Borrelia burgdorferi sensu stricto: Novel strains from Mexican wild rodents.
Colunga-Salas P; Hernández-Canchola G; Sánchez-Montes S; Lozano-Sardaneta YN; Becker I
Transbound Emerg Dis; 2021 May; 68(3):1263-1274. PubMed ID: 32772436
[TBL] [Abstract][Full Text] [Related]
33. DNA vaccines expressing a fusion product of outer surface proteins A and C from Borrelia burgdorferi induce protective antibodies suitable for prophylaxis but Not for resolution of Lyme disease.
Wallich R; Siebers A; Jahraus O; Brenner C; Stehle T; Simon MM
Infect Immun; 2001 Apr; 69(4):2130-6. PubMed ID: 11254567
[TBL] [Abstract][Full Text] [Related]
34. Identification of a defined linear epitope in the OspA protein of the Lyme disease spirochetes that elicits bactericidal antibody responses: Implications for vaccine development.
Izac JR; Oliver LD; Earnhart CG; Marconi RT
Vaccine; 2017 May; 35(24):3178-3185. PubMed ID: 28479174
[TBL] [Abstract][Full Text] [Related]
35. A systemic approach to identify non-abundant immunogenic proteins in Lyme disease pathogens.
Yaş OB; Coleman AS; Lipman RM; Sharma K; Raghunandanan S; Alanazi F; Rana VS; Kitsou C; Yang X; Pal U
mSystems; 2024 Jan; 9(1):e0108723. PubMed ID: 38078774
[No Abstract] [Full Text] [Related]
36. Lyme borreliosis in transgenic mice tolerant to Borrelia burgdorferi OspA or B.
Fikrig E; Tao H; Chen M; Barthold SW; Flavell RA
J Clin Invest; 1995 Oct; 96(4):1706-14. PubMed ID: 7560061
[TBL] [Abstract][Full Text] [Related]
37. Selective association of outer surface lipoproteins with the lipid rafts of Borrelia burgdorferi.
Toledo A; Crowley JT; Coleman JL; LaRocca TJ; Chiantia S; London E; Benach JL
mBio; 2014 Mar; 5(2):e00899-14. PubMed ID: 24618252
[TBL] [Abstract][Full Text] [Related]
38. Verification and dissection of the ospC operator by using flaB promoter as a reporter in Borrelia burgdorferi.
Xu Q; McShan K; Liang FT
Microb Pathog; 2008 Jul; 45(1):70-8. PubMed ID: 18479884
[TBL] [Abstract][Full Text] [Related]
39. Alternate sigma factor RpoS is required for the in vivo-specific repression of Borrelia burgdorferi plasmid lp54-borne ospA and lp6.6 genes.
Caimano MJ; Eggers CH; Gonzalez CA; Radolf JD
J Bacteriol; 2005 Nov; 187(22):7845-52. PubMed ID: 16267308
[TBL] [Abstract][Full Text] [Related]
40. The novel Lyme borreliosis vaccine VLA15 shows broad protection against Borrelia species expressing six different OspA serotypes.
Comstedt P; Schüler W; Meinke A; Lundberg U
PLoS One; 2017; 12(9):e0184357. PubMed ID: 28863166
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
